Dr. Jeffrey Bruce, Edgar M. Housepian Professor of Neurological Surgery at Columbia University Medical Center, is one of the senior authors of a paper on brain tumor treatment that was presented at the recent annual meeting of the Congress of Neurological Surgeons (CNS).
The paper titled, Effect Of Pretreatment Lymphopenia On Survival In Patients With Recurrent Glioblastoma Receiving Immunotherapy, analyzed the impact of tumor-caused immune system suppression on the outcomes of patients receiving a brain tumor vaccine. They concluded that this can be a factor and “should be considered when selecting patients for future vaccine clinical trials.”
Co-authors of the paper included: Orin Bloch, Yelena S. Fuks, Manish Kumar Aghi, Michael William McDermott, Mitchel S. Berger, Andrew E. Sloan, Jeffrey N. Bruce, and Andrew T. Parsa.
Dr. Bruce is Columbia Neurosurgery’s Director of the Bartoli Brain Tumor Research Laboratory and Co-Director of their Brain Tumor Center and specializes in the burgeoning field of brain tumor immunotherapy. He is also on the advisory board of the CNS/AANS Joint Section on Tumors.
You have added pages to your clipboard. Please log in or create an account to share them or use later.
You are now being taken to Columbia Neurosurgery's site dedicated to the spine.
Use this button to save pages to your clipboard for future use.OK. Got it.